SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-012835
Filing Date
2020-11-05
Accepted
2020-11-05 16:03:38
Documents
80
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q kala-20200930x10q.htm   iXBRL 10-Q 2034797
2 EX-31.1 kala-20200930xex31d1.htm EX-31.1 15225
3 EX-31.2 kala-20200930xex31d2.htm EX-31.2 15185
4 EX-32.1 kala-20200930xex32d1.htm EX-32.1 6724
5 EX-32.2 kala-20200930xex32d2.htm EX-32.2 6823
  Complete submission text file 0001558370-20-012835.txt   7570230

Data Files

Seq Description Document Type Size
6 EX-101.SCH kala-20200930.xsd EX-101.SCH 54902
7 EX-101.CAL kala-20200930_cal.xml EX-101.CAL 46829
8 EX-101.DEF kala-20200930_def.xml EX-101.DEF 211461
9 EX-101.LAB kala-20200930_lab.xml EX-101.LAB 486976
10 EX-101.PRE kala-20200930_pre.xml EX-101.PRE 382341
11 EXTRACTED XBRL INSTANCE DOCUMENT kala-20200930x10q_htm.xml XML 1236463
Mailing Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472 781-996-5252
Kala Pharmaceuticals, Inc. (Filer) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38150 | Film No.: 201290366
SIC: 2834 Pharmaceutical Preparations